Latest News

Pfizer remains a Buy, with valuation reflecting LOE risks and attractive risk-reward as the company executes on post-LOE growth strategies. PFE delivered a strong quarter, raising revenue guidance to

Connecting Excellence Group Plc (AQSE:XCE, OTCQB:XCELF) announced it has raised £600,000 through a share subscription to fund its Bitcoin treasury, acquisition strategy and hiring plans, with strategi

Shopify partners with Meta to enable Muse AI-driven purchases via Shop Pay after Amazon blocks Muse from its platform. Alibaba advances its AI ambitions, detailing the Qwen 4 model in training and pla

WisdomAI's agentic analytics platform — natively embedded in Tera — delivers natural-language analytics, single-prompt Live Apps, and proactive AI agents across all enterprise data, achieving 95%+ ins

Oracle laid off over 500 US employees from its cloud infrastructure division last week, per docs obtained by BI. The cuts fell hardest on managers, engineers, software developers, and data center supp

China's gold imports hit a monthly high in August, with the standout performance helping to push the country's gold imports to a record high over 1,100 tonnes year-to-date, China's General Administrat

Genmab A/S (GMAB) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Insmed is rated Buy, driven by Brinsupri's blockbuster launch and strong TPIP Phase 2b data. Brinsupri generated $517m in 1H 2026, faces minimal competition, and targets $7bn+ peak sales with COPD/ast

I rate AN2 Therapeutics a speculative buy, with a risk-adjusted base-case valuation of approximately $12 per share versus its September 18 closing price of $5.05. Epetraborole failed in treatment-refr

For most of the past two years, NVIDIA Corporation NASDAQ: NVDA has stood at the summit of the stock market. As the chipmaker whose processors power much of the artificial intelligence boom, it was pe

J&J Snack Foods is rated BUY, supported by a 4% dividend yield, strong cash generation, and a net cash balance sheet. JJSF's stock trades at a 55% discount to recent peak EV/EBITDA multiples, reflecti

Trump-Xi may extend the trade truce, but firm tariff cuts and timelines are needed to prevent a "sell the fact" reversal. Rare earth licences and AI chip rules are the key swing factors for USD/CNH, H

While Tesla (NASDAQ: TSLA) maintained electric vehicle (EV) market share dominance in the first half (H1) of 2026 with roughly 52.3%, its Cybertruck has been severely underperforming.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their Options If you purchased or acq

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Blaize To Contact Him Directly To Discuss Their Options If you purchased or acquired

Accenture plc remains undervalued, trading at a 24% discount to its $244 intrinsic value, and is rated a solid 'Buy.' AI poses risks to consulting revenue and pricing, but ACN's partnerships with Goog

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Datavault AI To Contact Him Directly To Discuss Their Options If you purchased or acq

Walmart and Target show potential recovery setups while Costco approaches a key earnings catalyst.

Gemini Space Station, Inc. is set for a bullish rally as crypto prices rebound and business prospects improve. GEMI's services and non-exchange revenues are surging, offsetting exchange revenue declin

Cybin Inc. (HELP) Shareholder/Analyst Call Prepared Remarks Transcript